Field | Row 1 |
---|---|
adsh | 0001558370-25-007747 |
cik | 1819411 |
name | GAIN THERAPEUTICS, INC. |
sic | 2834 |
countryba | US |
stprba | MD |
cityba | BETHESDA |
zipba | 20814 |
bas1 | 4800 HAMPDEN LANE |
bas2 | SUITE 200 |
baph | (301) 500-1556 |
countryma | US |
stprma | MD |
cityma | BETHESDA |
zipma | 20814 |
mas1 | 4800 HAMPDEN LANE |
mas2 | SUITE 200 |
countryinc | US |
stprinc | DE |
ein | 851726310 |
former | |
changed | |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250514 |
accepted | 2025-05-14 16:09:00.0 |
prevrpt | 0 |
detail | 1 |
instance | ganx-20250331x10q_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001558370-25-007747 | 20250331 | Accounts Payable Current | 2151410.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
0001558370-25-007747 | 20250331 | Assets Noncurrent | 472647.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Cash And Cash Equivalents At Carrying Value | 4745080.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Money Market Funds; | ||
0001558370-25-007747 | 20250331 | Common Stock Value | 2875.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Comprehensive Income Net Of Tax | -4239572.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Depreciation Depletion And Amortization | 20528.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 268077.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Interest Income Expense Nonoperating Net | 115303.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Interest Income Expense Nonoperating Net | 40413.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Liabilities Noncurrent | 815921.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Operating Lease Right Of Use Asset | 183664.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | -4826.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | 4328.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -230792.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20240331 | Payments Of Stock Issuance Costs | 280867.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Repayments Of Short Term Debt | 22242.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Retained Earnings Accumulated Deficit | -81194908.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Share Based Compensation | 190424.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Shares Outstanding | 27132588.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20231231 | Stockholders Equity | 73113079.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20240331 | Stockholders Equity | 1805.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20241231 | Stockholders Equity | 2713.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 15983.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 17978951.0000 | shares | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1314914.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Common Stock Shares Outstanding | 27132588.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Common Stock Shares Outstanding | 28746041.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Deferred Income Current | 252211.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 703593.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Increase Decrease In Operating Capital | -416805.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 295447.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Operating Expenses | 4369376.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Operating Income Loss | -4377700.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Operating Lease Right Of Use Asset | 219715.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | -1086.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Other Liabilities Current | 2397386.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Other Noncash Income Expense | 200146.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Prepaid Expense And Other Assets Current | 945536.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Profit Loss | -4530058.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Shares Outstanding | 28746041.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20231231 | Stockholders Equity | 12578224.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Stockholders Equity | -85724966.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Shares Warrants Exercised | 1787443.0000 | shares | 1 | 0001558370-25-007747 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value New Issues At Market Offering | 2419319.0000 | USD | 1 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 2.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Warrants Exercised | 179.0000 | USD | 1 | 0001558370-25-007747 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20241231 | Assets | 12123884.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Assets Current | 11602478.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Capitalized Computer Software Net | 126291.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Cash And Cash Equivalents At Carrying Value | 9070102.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9102644.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Deposits And Other Assets Noncurrent | 32109.0000 | USD | 0 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20250331 | Depreciation Depletion And Amortization | 20660.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -442503.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Income Loss For Period | -20411191.0000 | USD | 0 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -4429549.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Income Tax Expense Benefit | 19874.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Income Tax Expense Benefit | 100509.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Increase Decrease In Other Noncurrent Assets | -927.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Liabilities | 5844353.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Long Term Debt Noncurrent | 328327.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Net Cash Provided By Used In Operating Activities | -3821527.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset | -30118.0000 | USD | 1 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20250331 | Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset | -23176.0000 | USD | 1 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | -1086.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 127684.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
0001558370-25-007747 | 20250331 | Proceeds From Issuance Of Common Stock In At Market Offerings | 5370000.0000 | USD | 2 | 0001558370-25-007747 | Subsidiary Sale Of Stock= At Market Offering Program2024; | ||
0001558370-25-007747 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 3018750.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Property Plant And Equipment Net | 103619.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Restricted Cash Noncurrent | 31695.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20231231 | Stockholders Equity | 1621.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Stockholders Equity | 21863.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Shares New Issues At Market Offerings | 1094701.0000 | shares | 1 | 0001558370-25-007747 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Shares Warrants Exercised | 454893.0000 | shares | 1 | 0001558370-25-007747 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 57709.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Warrants Exercised | 100225.0000 | USD | 1 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 17978951.0000 | shares | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Additional Paid In Capital | 88779318.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Capitalized Computer Software Net | 134268.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Cash And Cash Equivalents At Carrying Value | 4902147.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash; | ||
0001558370-25-007747 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Common Stock Value | 2713.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Earnings Per Share Basic | -0.1600 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -3994320.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Increase Decrease In Other Noncurrent Assets | 3021.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Liabilities Current | 5028432.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Net Cash Provided By Used In Investing Activities | 3018750.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Operating Lease Liability Current | 160913.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Proceeds From Issuance Of Common Stock In At Market Offerings | 2420000.0000 | USD | 1 | 0001558370-25-007747 | Subsidiary Sale Of Stock= At Market Offering Program2024; | ||
0001558370-25-007747 | 20250331 | Research And Development Expense | 2257010.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20231231 | Shares Outstanding | 16206680.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20241231 | Stockholders Equity | 88779318.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20241231 | Stockholders Equity | -81194908.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007747 | 20250331 | Stockholders Equity | 2875.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value New Issues At Market Offering | 109.0000 | USD | 1 | 0001558370-25-007747 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value Share Based Compensation | 423139.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value Share Based Compensation | 6.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value Warrants Exercised | 47.0000 | USD | 1 | 0001558370-25-007747 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -247549.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Assets | 11624064.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Cash And Cash Equivalents At Carrying Value | 5640783.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash; | ||
0001558370-25-007747 | 20250331 | Comprehensive Income Net Of Tax | -4402374.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Deferred Income Taxes And Other Tax Receivable Current | 271079.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Earnings Per Share Diluted | -0.1600 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | -100586.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | General And Administrative Expense | 1870794.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Income Loss For Period | -4530058.0000 | USD | 0 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20241231 | Liabilities Current | 3911321.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Net Cash Provided By Used In Operating Activities | -3586583.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Operating Income Loss | -4369376.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Operating Lease Liability Current | 148674.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Prepaid Expense And Other Assets Current | 1833659.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Research And Development Expense | 2506906.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20231231 | Stockholders Equity | 247241.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20231231 | Stockholders Equity | -60783717.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007747 | 20241231 | Stockholders Equity | 7339574.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Stockholders Equity | -247549.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value New Issues At Market Offering | 2419210.0000 | USD | 1 | 0001558370-25-007747 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Share Based Compensation | 145473.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value Warrants Exercised | 47.0000 | USD | 1 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 28685417.0000 | shares | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -119865.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10417558.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1156139.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Deferred Income Taxes And Other Tax Receivable Current | 247656.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Earnings Per Share Diluted | -0.2200 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | General And Administrative Expense | 2112366.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Increase Decrease In Deferred Liabilities | -88631.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Increase Decrease In Operating Capital | -158776.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 844484.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Liabilities Noncurrent | 872989.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Long Term Debt Current | 110177.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Long Term Debt Current | 113121.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Net Cash Provided By Used In Financing Activities | -145803.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Net Income Loss | -4530058.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Net Income Loss | -4530058.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007747 | 20250331 | Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | -4826.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -230792.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Proceeds From Issuance Of Common Stock In At Market Offerings | 2419320.0000 | USD | 1 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20250331 | Stockholders Equity | 5779711.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Stockholders Equity | -119865.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 31125.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 63859.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Share Based Compensation | 145470.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 57711.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Warrants Exercised | 100046.0000 | USD | 1 | 0001558370-25-007747 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20241231 | Accounts Payable Current | 946259.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Additional Paid In Capital | 91621667.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Assets Current | 11151417.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Assets Noncurrent | 521406.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Cash And Cash Equivalents At Carrying Value | 10385863.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Cash And Cash Equivalents At Carrying Value | 4167955.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Money Market Funds; | ||
0001558370-25-007747 | 20250331 | Common Stock Shares Issued | 28746041.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Deferred Income Current | 217841.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Defined Benefit Pension Plan Liabilities Noncurrent | 443623.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Defined Benefit Pension Plan Liabilities Noncurrent | 470856.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Deposits And Other Assets Noncurrent | 32641.0000 | USD | 0 | 0001558370-25-007747 | |||
0001558370-25-007747 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 109535.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Liabilities | 4784310.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Liabilities And Stockholders Equity | 11624064.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Long Term Debt Noncurrent | 314476.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Net Cash Provided By Used In Financing Activities | 2397078.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Net Income Loss | -4014194.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 122858.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20250331 | Other Noncash Income Expense | -109591.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Proceeds From Stock Options Exercised | 57711.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Proceeds From Warrant Exercises | 100225.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Profit Loss | -4014194.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Repayments Of Short Term Debt | 22872.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Restricted Cash Noncurrent | 32542.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Share Based Compensation | 419504.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Shares Outstanding | 18041231.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20240331 | Stockholders Equity | 8642061.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Stockholders Equity | 91621667.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Shares Warrants Exercised | 454893.0000 | shares | 1 | 0001558370-25-007747 | Class Of Warrant Or Right= Pre Funded Warrants; Subsidiary Sale Of Stock= Public Offering; | ||
0001558370-25-007747 | 20240331 | Stock Issued During Period Value Share Based Compensation | 3.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007747 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 11828970.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10672831.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Common Stock Shares Issued | 27132588.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Deferred Income Noncurrent | 47441.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Earnings Per Share Basic | -0.2200 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 1114140.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Increase Decrease In Deferred Liabilities | 41798.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Liabilities And Stockholders Equity | 12123884.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Net Income Loss | -4014194.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007747 | 20240331 | Operating Expenses | 4377700.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Operating Lease Liability Noncurrent | 53598.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Operating Lease Liability Noncurrent | 30589.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | 4328.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001558370-25-007747 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 122858.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -225378.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Other Liabilities Current | 2441761.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20250430 | Proceeds From Issuance Of Common Stock In At Market Offerings | 2170000.0000 | USD | 0 | 0001558370-25-007747 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= At Market Offering Program2024; | ||
0001558370-25-007747 | 20250331 | Property Plant And Equipment Net | 97509.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20241231 | Retained Earnings Accumulated Deficit | -60783717.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007747 | 20240331 | Stockholders Equity | 73416304.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007747 | 20240331 | Stockholders Equity | -64797911.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007747 | 20250331 | Stock Issued During Period Value Share Based Compensation | 423145.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007747 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 28685417.0000 | shares | 1 | us-gaap/2024 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Deferred Income Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income, Current | Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Increase Decrease In Operating Capital | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Operating Capital | The increase (decrease) during the reporting period of all assets and liabilities used in operating activities. |
Interest Income Expense Nonoperating Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Increase Decrease In Deferred Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Liabilities | Change during the period in carrying value for all deferred liabilities due within one year or operating cycle. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent | Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent. |
Repayments Of Short Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Short-Term Debt | The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Proceeds From Issuance Of Common Stock In At Market Offerings | 0001558370-25-007747 | 1 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock in At The Market Offerings | Proceeds from Issuance of Common Stock in At-the-market Offerings |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Deposits And Other Assets Noncurrent | 0001558370-25-007747 | 1 | 0 | monetary | I | D | Deposits And Other Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer and noncurrent assets classified as other. |
Stock Issued During Period Value Warrants Exercised | 0001558370-25-007747 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, Warrants Exercised | Value of stock issued as a result of exercise of warrants. |
Deferred Income Taxes And Other Tax Receivable Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Taxes and Other Tax Receivable, Current | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other tax receivables expected to be realized or consumed within one year or operating cycle, if longer. |
Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Defined Benefit Pension Plan Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liability, Defined Benefit Pension Plan, Noncurrent | Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset | 0001558370-25-007747 | 1 | 0 | monetary | D | D | Non-cash Increase (Decrease) in Defined Benefit Pension Plan, Obligation (Asset) | Non-cash Increase (Decrease) in Defined Benefit Pension Plan, Obligation (Asset) |
Capitalized Computer Software Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Capitalized Computer Software, Net | The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date. |
Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Stock Issued During Period Shares New Issues At Market Offerings | 0001558370-25-007747 | 1 | 0 | shares | D | Stock Issued During Period, Shares, New Issues, At the Market Offerings | Stock Issued During Period, Shares, New Issues, At-the-Market-Offerings. | |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
Income Loss For Period | 0001558370-25-007747 | 1 | 0 | monetary | I | C | Income Loss For The Period | The current period income or loss. |
Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Stock Issued During Period Shares Warrants Exercised | 0001558370-25-007747 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Warrants Exercised | Number of shares issued as a result of exercise of warrants. | |
Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Stock Issued During Period Value New Issues At Market Offering | 0001558370-25-007747 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues, At the Market Offering | Equity impact of the value of new stock issued during the period in at the market offerings. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Deferred Income Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income, Noncurrent | Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. |
Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
Long Term Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001558370-25-007747 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0001558370-25-007747 | 2 | 4 | BS | 0 | H | Deferred Income Taxes And Other Tax Receivable Current | us-gaap/2024 | Tax credits | 0 |
0001558370-25-007747 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
0001558370-25-007747 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0001558370-25-007747 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0001558370-25-007747 | 2 | 9 | BS | 0 | H | Capitalized Computer Software Net | us-gaap/2024 | Internal-use software, net | 0 |
0001558370-25-007747 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
0001558370-25-007747 | 2 | 11 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
0001558370-25-007747 | 2 | 12 | BS | 0 | H | Deposits And Other Assets Noncurrent | 0001558370-25-007747 | Long-term deposits and other noncurrent assets | 0 |
0001558370-25-007747 | 2 | 13 | BS | 0 | H | Assets Noncurrent | us-gaap/2024 | Total noncurrent assets | 0 |
0001558370-25-007747 | 2 | 14 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0001558370-25-007747 | 2 | 18 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
0001558370-25-007747 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability - current | 0 |
0001558370-25-007747 | 2 | 20 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
0001558370-25-007747 | 2 | 21 | BS | 0 | H | Deferred Income Current | us-gaap/2024 | Deferred grant income - current | 0 |
0001558370-25-007747 | 2 | 22 | BS | 0 | H | Long Term Debt Current | us-gaap/2024 | Loans - current | 0 |
0001558370-25-007747 | 2 | 23 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0001558370-25-007747 | 2 | 25 | BS | 0 | H | Defined Benefit Pension Plan Liabilities Noncurrent | us-gaap/2024 | Defined benefit pension plan | 0 |
0001558370-25-007747 | 2 | 26 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability - noncurrent | 0 |
0001558370-25-007747 | 2 | 27 | BS | 0 | H | Deferred Income Noncurrent | us-gaap/2024 | Deferred grant income - noncurrent | 0 |
0001558370-25-007747 | 2 | 28 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Loans - noncurrent | 0 |
0001558370-25-007747 | 2 | 29 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total noncurrent liabilities | 0 |
0001558370-25-007747 | 2 | 30 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0001558370-25-007747 | 2 | 32 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.0001 par value; 10,000,000 shares authorized; nil shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
0001558370-25-007747 | 2 | 33 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value: 50,000,000 shares authorized; 28,746,041 and 27,132,588 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
0001558370-25-007747 | 2 | 34 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
0001558370-25-007747 | 2 | 35 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
0001558370-25-007747 | 2 | 36 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0001558370-25-007747 | 2 | 37 | BS | 0 | H | Income Loss For Period | 0001558370-25-007747 | Loss of the period | 0 |
0001558370-25-007747 | 2 | 38 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
0001558370-25-007747 | 2 | 39 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
0001558370-25-007747 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
0001558370-25-007747 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
0001558370-25-007747 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
0001558370-25-007747 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
0001558370-25-007747 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
0001558370-25-007747 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0001558370-25-007747 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares, issued | 0 |
0001558370-25-007747 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares, outstanding | 0 |
0001558370-25-007747 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 1 |
0001558370-25-007747 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 1 |
0001558370-25-007747 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 1 |
0001558370-25-007747 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0001558370-25-007747 | 4 | 7 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2024 | Interest income, net | 0 |
0001558370-25-007747 | 4 | 8 | IS | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign exchange (loss) gain, net | 0 |
0001558370-25-007747 | 4 | 9 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income tax | 0 |
0001558370-25-007747 | 4 | 10 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax | 1 |
0001558370-25-007747 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007747 | 4 | 13 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share attributable to common stockholders - Basic | 0 |
0001558370-25-007747 | 4 | 14 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share attributable to common stockholders - Diluted | 0 |
0001558370-25-007747 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average common shares - Basic | 0 |
0001558370-25-007747 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average common shares - Diluted | 0 |
0001558370-25-007747 | 5 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007747 | 5 | 2 | CI | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized gain on available-for-sale marketable securities | 0 |
0001558370-25-007747 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Changes in defined benefit pension plan obligation, net of tax | 1 |
0001558370-25-007747 | 5 | 4 | CI | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation | 0 |
0001558370-25-007747 | 5 | 5 | CI | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive income (loss), net of tax | 0 |
0001558370-25-007747 | 5 | 6 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
0001558370-25-007747 | 6 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, beginning of period | 0 |
0001558370-25-007747 | 6 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, beginning of period (in shares) | 0 |
0001558370-25-007747 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Stock-based compensation (Note 15) | 0 |
0001558370-25-007747 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Stock-based compensation (Note 15) (in shares) | 0 |
0001558370-25-007747 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options (Note 14) | 0 |
0001558370-25-007747 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (Note 14) (in shares) | 0 |
0001558370-25-007747 | 6 | 18 | EQ | 0 | H | Stock Issued During Period Value Warrants Exercised | 0001558370-25-007747 | Exercise of warrants (Note 14) | 0 |
0001558370-25-007747 | 6 | 19 | EQ | 0 | H | Stock Issued During Period Shares Warrants Exercised | 0001558370-25-007747 | Exercise of warrants (Note 14) (shares) | 0 |
0001558370-25-007747 | 6 | 20 | EQ | 0 | H | Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Changes in defined benefit pension plan obligation (Note 11) | 1 |
0001558370-25-007747 | 6 | 21 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation | 0 |
0001558370-25-007747 | 6 | 22 | EQ | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Net unrealized gain on available-for-sale securities (Note 5) | 0 |
0001558370-25-007747 | 6 | 23 | EQ | 0 | H | Stock Issued During Period Value New Issues At Market Offering | 0001558370-25-007747 | Issuance of shares in at-the-market ("ATM") offering (Note 14) | 0 |
0001558370-25-007747 | 6 | 24 | EQ | 0 | H | Stock Issued During Period Shares New Issues At Market Offerings | 0001558370-25-007747 | Issuance of shares in at-the-market ("ATM") offering (Note 14) (shares) | 0 |
0001558370-25-007747 | 6 | 25 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007747 | 6 | 26 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, end of period | 0 |
0001558370-25-007747 | 6 | 27 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, end of period (in shares) | 0 |
0001558370-25-007747 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007747 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
0001558370-25-007747 | 7 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock based compensation expense | 0 |
0001558370-25-007747 | 7 | 6 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Other non-cash items | 1 |
0001558370-25-007747 | 7 | 8 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
0001558370-25-007747 | 7 | 9 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Long term deposit and other noncurrent assets | 1 |
0001558370-25-007747 | 7 | 10 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and other current liabilities | 0 |
0001558370-25-007747 | 7 | 11 | CF | 0 | H | Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset | 0001558370-25-007747 | Defined benefit pension plan | 0 |
0001558370-25-007747 | 7 | 12 | CF | 0 | H | Increase Decrease In Deferred Liabilities | us-gaap/2024 | Deferred grant income | 0 |
0001558370-25-007747 | 7 | 13 | CF | 0 | H | Increase Decrease In Operating Capital | us-gaap/2024 | Total changes in operating assets and liabilities | 1 |
0001558370-25-007747 | 7 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Cash used in operating activities | 0 |
0001558370-25-007747 | 7 | 16 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Maturities of marketable securities | 0 |
0001558370-25-007747 | 7 | 17 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Cash provided by investing activities | 0 |
0001558370-25-007747 | 7 | 19 | CF | 0 | H | Proceeds From Issuance Of Common Stock In At Market Offerings | 0001558370-25-007747 | Net proceeds from issuance of shares in ATM offering (Note 14) | 0 |
0001558370-25-007747 | 7 | 20 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Net proceeds from the exercise of warrants (Note 14) | 0 |
0001558370-25-007747 | 7 | 21 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Net proceeds from the exercise of stock options (Note 15) | 0 |
0001558370-25-007747 | 7 | 22 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payments of offering costs (Note 14) | 1 |
0001558370-25-007747 | 7 | 23 | CF | 0 | H | Repayments Of Short Term Debt | us-gaap/2024 | Payments of current portion of long-term debt (Note 12) | 1 |
0001558370-25-007747 | 7 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Cash provided by (used in) financing activities | 0 |
0001558370-25-007747 | 7 | 25 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of exchange rate changes | 0 |
0001558370-25-007747 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash, cash equivalents and restricted cash | 0 |
0001558370-25-007747 | 7 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of period | 0 |
0001558370-25-007747 | 7 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |